I know many of you are overwhelmed with often-conflicting information on coronavirus and COVID-19. As a doctor and researcher, the health of the bleeding disorder community is my highest priority. Every Thursday, I will be sending you vetted,…
BD is conducting a voluntary medical device recall for multiple lots of the BD PosiFlush™ SF (Sterile Field) Saline Flush Syringe 10mL identified in the Table above and Attachment A. This product has been confirmed to exhibit holes…
The Centers for Disease Control and Prevention (CDC) are currently soliciting written comments on pain and pain management, including those relevant to the benefits and harms of opioid use, to help inform the agency’s understanding of the subject…
Join us on Friday, April 24th at 6:00pm ET for NHF's townhall webinar: Staying Active: Coping During COVID-19. Physical activity is important during this pandemic for adults and children. Kimberly Baumann, MPT a Physical Therapist from the…
Fill out my Wufoo form!
BioMarin has released an update on the impact of COVID-19 on the clinical trial program for their investigational hemophilia A gene therapy valoctocogene roxaparvovec, developed for the treatment of adults with severe hemophilia A.
The release…
I know many of you are overwhelmed with often-conflicting information on coronavirus and COVID-19. As a doctor and researcher, the health of the bleeding disorder community is my highest priority. Every Thursday, I will be sending you vetted,…
Genentech recently distributed a notice relevant to its product Hemlibra®, reminding health care providers that it is known to interfere with certain laboratory assays used to measure blood coagulation. These tests are often used…
Fill out my Wufoo form!
NHF is posting all communications from specialty pharmacy providers regarding any potential effects that the COVID-19 pandemic could have on their ability to distribute product and provide services. If you have any questions about your…